“Nail Outcome Improvements with Certolizumab Pegol in Moderate to Severe Plaque Psoriasis: Results from Phase 3 Trials” (2019) SKIN The Journal of Cutaneous Medicine, 3, p. S38. doi:10.25251/skin.3.supp.38.